| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. | Chief Financial Officer | Common Stock | 275K | $478K | $1.74 | Mar 30, 2022 | Direct |
| Scholar Rock Holding Corp | Director | Common Stock | 13.5K | $121K | $8.99 | Jun 27, 2024 | Direct |
| Aldeyra Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 250K | Mar 30, 2022 | Direct | ||
| Omega Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 110K | Feb 7, 2024 | Direct | ||
| Scholar Rock Holding Corp | Director | Stock Option (Right to Buy) | 18K | Jun 27, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | Jun 27, 2024 | 2 | $0 | 4 | Jul 1, 2024 | Director |
| OMGA | Omega Therapeutics, Inc. | Feb 7, 2024 | 1 | $0 | 4 | Feb 9, 2024 | Chief Financial Officer |
| SRRK | Scholar Rock Holding Corp | Jun 21, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
| OMGA | Omega Therapeutics, Inc. | Feb 28, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Chief Financial Officer |
| OMGA | Omega Therapeutics, Inc. | Oct 27, 2022 | 1 | $0 | 4 | Oct 28, 2022 | Chief Financial Officer |
| OMGA | Omega Therapeutics, Inc. | May 31, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Chief Financial Officer |
| SRRK | Scholar Rock Holding Corp | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| OMGA | Omega Therapeutics, Inc. | May 23, 2022 | 0 | $0 | 3 | Jun 2, 2022 | Chief Financial Officer |
| ALDX | Aldeyra Therapeutics, Inc. | Mar 30, 2022 | 2 | $0 | 4 | Apr 1, 2022 | Chief Financial Officer |